Stacey Jennifer Evans
Executive VP & General Counsel at AUXILIUM PHARMACEUTICALS INC
- Sold, on record
- $745k
- Dollars the filings state
- Form 4 sales
- 4
- Latest Sep 14, 2009
- Form 144 notices
- 0
- Proposed sales
- Quarters with a sale
- 0 of the last 8
- No sale in two years
- Companies
- 1
- Filed as an executive or holder
Companies
- AUXILIUM PHARMACEUTICALS INCExecutive VP & General Counsel
Sales by reason
0
Routine
0
Plan not stated
0
No plan
4
Unusual
Form 4 sales per year, every sale on record.
Timeline
- Sep 14, 2009Unusual
Sold 40.3% of their holdings
$224k6,333 shares at $35.43
- Jul 24, 2009Unusual
Sold 40.3% of their holdings
$203k6,333 shares at $32.13
- Jan 6, 2009Unusual
Sold 47.8% of their holdings
$179k5,970 shares at $30.04
- Dec 18, 2008Unusual
Sold 43.4% of their holdings
$138k5,000 shares at $27.59
4 of 4
Every transaction
| Traded | Filed | Stock | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|
| Aug 14, 2026 | Aug 14, 2026 | NEOG | Chief Legal Officer | AwardedCommon Stock (Right to Buy) | 196,276 | 196,276 | SEC | ||
| Aug 14, 2026 | Aug 14, 2026 | NEOG | Chief Legal Officer | Awarded | 38,627 | $11.65 | $450k | 38,627 | SEC |
| Jun 24, 2026 | Jun 26, 2026 | CNTX | Director | AwardedStock Option (right to buy) | 45,000 | 45,000 | SEC | ||
| May 1, 2026 | May 4, 2026 | NEOG | Chief Legal Officer | AwardedCommon Stock (Right to Buy) | 89,520 | 89,520 | SEC | ||
| May 1, 2026 | May 4, 2026 | NEOG | Chief Legal Officer | Awarded | 39,349 | $9.53 | $375k | 39,349 | SEC |
| Jun 12, 2025 | Jun 12, 2025 | CNTX | Director | AwardedStock Option (right to buy) | 123,500 | 123,500 | SEC | ||
| Jun 13, 2024 | Jun 14, 2024 | CNTX | Director | AwardedStock Option (right to buy) | 25,000 | 25,000 | SEC | ||
| May 31, 2023 | May 31, 2023 | CNTX | Director | AwardedStock Option (right to buy) | 25,000 | 25,000 | SEC | ||
| Feb 25, 2023 | Feb 28, 2023 | Galera Therapeutics, Inc. | Officer | AwardedStock Option (Right to Buy) | 135,000 | 135,000 | SEC | ||
| Jun 2, 2022 | Jun 3, 2022 | CNTX | Director | AwardedStock Option (right to buy) | 25,000 | 25,000 | SEC | ||
| Feb 28, 2022 | Mar 2, 2022 | Galera Therapeutics, Inc. | Officer | AwardedStock Option (Right to Buy) | 75,000 | 75,000 | SEC | ||
| Oct 8, 2021 | Oct 12, 2021 | Galera Therapeutics, Inc. | Officer | AwardedStock Option (Right to Buy) | 130,000 | 130,000 | SEC | ||
| May 28, 2015 | Jun 1, 2015 | ANTARES PHARMA, INC. | SVP, General Counsel & Secty | Withheld for tax | 2,469 | $2.18 | $5k | 21,803 | SEC |
| May 28, 2015 | Jun 1, 2015 | ANTARES PHARMA, INC. | SVP, General Counsel & Secty | AwardedStock option (right to buy) | 142,550 | 142,550 | SEC | ||
| May 28, 2015 | Jun 1, 2015 | ANTARES PHARMA, INC. | SVP, General Counsel & Secty | Awarded | 70,239 | 92,042 | SEC | ||
| Mar 10, 2015 | Mar 12, 2015 | ANTARES PHARMA, INC. | SVP, General Counsel & Secty | AwardedStock option (right to buy) | 47,000 | 47,000 | SEC | ||
| May 29, 2014 | Jun 2, 2014 | ANTARES PHARMA, INC. | SVP, General Counsel & Secty | AwardedStock option (right to buy) | 100,000 | 100,000 | SEC | ||
| May 29, 2014 | Jun 2, 2014 | ANTARES PHARMA, INC. | SVP, General Counsel & Secty | Awarded | 72,816 | 72,816 | SEC | ||
| Feb 28, 2011 | Apr 4, 2011 | AUXILIUM PHARMACEUTICALS INC | Executive VP & General Counsel | Withheld for tax | 941 | $22.47 | $21k | 16,878 | SEC |
| Feb 17, 2011 | Feb 22, 2011 | AUXILIUM PHARMACEUTICALS INC | Executive VP & General Counsel | AwardedNonqualified Stock Option (Right to Buy) | 40,000 | 40,000 | SEC | ||
| Mar 12, 2010 | Mar 16, 2010 | AUXILIUM PHARMACEUTICALS INC | Executive VP & General Counsel | Withheld for tax | 941 | $30.20 | $28k | 17,819 | SEC |
| Feb 28, 2010 | Mar 2, 2010 | AUXILIUM PHARMACEUTICALS INC | Executive VP & General Counsel | AwardedNonqualified Stock Option (Right to Buy) | 35,000 | 35,000 | SEC | ||
| Feb 28, 2010 | Mar 2, 2010 | AUXILIUM PHARMACEUTICALS INC | Executive VP & General Counsel | Awarded | 9,378 | 18,760 | SEC | ||
| Sep 14, 2009 | Sep 16, 2009 | AUXILIUM PHARMACEUTICALS INC | Executive VP & General Counsel | Sold | 6,333 | $35.43 | $224k | 9,382 | SEC |
| Sep 14, 2009 | Sep 16, 2009 | AUXILIUM PHARMACEUTICALS INC | Executive VP & General Counsel | Exercised or settledNonqualified Stock Option (Right to Buy) | 6,333 | 37,363 | SEC | ||
| Sep 14, 2009 | Sep 16, 2009 | AUXILIUM PHARMACEUTICALS INC | Executive VP & General Counsel | Exercised options | 6,333 | $7.49 | $47k | 15,715 | SEC |
| Jul 24, 2009 | Jul 28, 2009 | AUXILIUM PHARMACEUTICALS INC | Executive VP & General Counsel | Sold | 6,333 | $32.13 | $203k | 9,382 | SEC |
| Jul 24, 2009 | Jul 28, 2009 | AUXILIUM PHARMACEUTICALS INC | Executive VP & General Counsel | Exercised or settledNonqualified Stock Option (Right to Buy) | 6,333 | 38,363 | SEC | ||
| Jul 24, 2009 | Jul 28, 2009 | AUXILIUM PHARMACEUTICALS INC | Executive VP & General Counsel | Exercised options | 6,333 | $7.49 | $47k | 15,715 | SEC |
| Feb 27, 2009 | Mar 3, 2009 | AUXILIUM PHARMACEUTICALS INC | Executive VP & General Counsel | AwardedNonqualified Stock Option (Right to Buy) | 20,000 | 20,000 | SEC | ||
| Feb 25, 2009 | Feb 27, 2009 | AUXILIUM PHARMACEUTICALS INC | Executive VP & General Counsel | AwardedNonqualified Stock Option (Right to Buy) | 30,900 | 30,900 | SEC | ||
| Jan 16, 2009 | Jan 21, 2009 | AUXILIUM PHARMACEUTICALS INC | Executive VP & General Counsel | Withheld for tax | 1,128 | $30.00 | $34k | 9,137 | SEC |
| Jan 16, 2009 | Jan 21, 2009 | AUXILIUM PHARMACEUTICALS INC | Executive VP & General Counsel | Awarded | 3,750 | 10,265 | SEC | ||
| Jan 6, 2009 | Jan 8, 2009 | AUXILIUM PHARMACEUTICALS INC | Executive VP & General Counsel | Sold | 5,970 | $30.04 | $179k | 6,515 | SEC |
| Jan 6, 2009 | Jan 8, 2009 | AUXILIUM PHARMACEUTICALS INC | Executive VP & General Counsel | Exercised or settledNonqualified Stock Option (Right to Buy) | 5,970 | 39,363 | SEC | ||
| Jan 6, 2009 | Jan 8, 2009 | AUXILIUM PHARMACEUTICALS INC | Executive VP & General Counsel | Exercised options | 5,970 | $7.14 | $43k | 12,485 | SEC |
| Dec 18, 2008 | Dec 22, 2008 | AUXILIUM PHARMACEUTICALS INC | Executive VP & General Counsel | Sold | 5,000 | $27.59 | $138k | 6,515 | SEC |
| Dec 18, 2008 | Dec 22, 2008 | AUXILIUM PHARMACEUTICALS INC | Executive VP & General Counsel | Exercised or settledNonqualified Stock Option (Right to Buy) | 5,000 | 105,000 | SEC | ||
| Dec 18, 2008 | Dec 22, 2008 | AUXILIUM PHARMACEUTICALS INC | Executive VP & General Counsel | Exercised options | 5,000 | $5.36 | $27k | 11,515 | SEC |
| Feb 22, 2008 | Feb 26, 2008 | AUXILIUM PHARMACEUTICALS INC | Executive VP & General Counsel | AwardedNonqualified Stock Options (Right to Buy) | 20,000 | 20,000 | SEC | ||
| Sep 19, 2007 | Nov 2, 2007 | AUXILIUM PHARMACEUTICALS INC | Executive VP & General Counsel | AwardedNonqualified Stock Option (Right to Buy) | 10,000 | 10,000 | SEC | ||
| Feb 23, 2007 | Feb 27, 2007 | AUXILIUM PHARMACEUTICALS INC | Executive VP & General Counsel | AwardedNonqualified Stocks Option (Right to Buy) | 40,000 | 40,000 | SEC | ||
| Jun 6, 2006 | Jun 8, 2006 | AUXILIUM PHARMACEUTICALS INC | Executive VP & General Counsel | AwardedNonqualified Stock Option (Right to Buy) | 45,000 | 45,000 | SEC |
Sales and notices (4)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Sep 14, 2009 | Sep 16, 2009 | AUXILIUM PHARMACEUTICALS INC | Executive VP & General Counsel | Form 4 sale | 6,333 | $224k | 40.3% | Unusual | SEC |
| Jul 24, 2009 | Jul 28, 2009 | AUXILIUM PHARMACEUTICALS INC | Executive VP & General Counsel | Form 4 sale | 6,333 | $203k | 40.3% | Unusual | SEC |
| Jan 6, 2009 | Jan 8, 2009 | AUXILIUM PHARMACEUTICALS INC | Executive VP & General Counsel | Form 4 sale | 5,970 | $179k | 47.8% | Unusual | SEC |
| Dec 18, 2008 | Dec 22, 2008 | AUXILIUM PHARMACEUTICALS INC | Executive VP & General Counsel | Form 4 sale | 5,000 | $138k | 43.4% | Unusual | SEC |